We've found 11 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
To own Globe Life today, you would need to believe its core life and health franchises can retain customer trust and keep generating solid underwriting and investment returns, despite heightened scrutiny of its sales culture. The short seller driven reputational shock makes near term sentiment the key catalyst, while the biggest current risk is that ongoing headlines translate into higher lapse rates, weaker new business, or renewed regulatory focus.
Against this backdrop, Globe Life’s recent pattern of affirming and modestly increasing its quarterly dividend, most recently to US$0.27 per share in early 2025, stands out as the most relevant announcement. For some shareholders, a consistent dividend track record can be a small counterweight to headline volatility, but it does not remove the underlying risks tied to reputation, investigations, and the company’s reliance on agent based distribution.
Yet behind the headlines, one risk that investors should be aware of is...
Read the full narrative on Globe Life (it's free!)
Globe Life's narrative projects $6.8 billion revenue and $1.3 billion earnings by 2028.
Uncover how Globe Life's forecasts yield a $168.30 fair value, a 21% upside to its current price.
Two fair value estimates from the Simply Wall St Community span a wide range, from US$168.30 up to about US$358.98, showing how far apart individual views can be. Readers should weigh these against the current reputational and regulatory risks that could affect Globe Life’s ability to sustain its traditional agent driven model and overall performance, and consider exploring several alternative viewpoints before drawing conclusions.
Explore 2 other fair value estimates on Globe Life - why the stock might be worth just $168.30!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Every day counts. These free picks are already gaining attention. See them before the crowd does:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com